The last time I spoke about Immunovant (IMVT) it was with respect to a Seeking Alpha article entitled "Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward". With respect to ...
Viking Therapeutics' VK2735, a dual GLP-1/GIP receptor agonist, shows promising results in Phase II trials for obesity treatment with potential for both subcutaneous and oral formulations. Despite ...
DUBLIN--(BUSINESS WIRE)--The "CDK4/6 Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report ...
Since the first CAR-T cell product was approved by the FDA in 2017, five additional CAR-T cell products have reached the market, all of which target CD19 or BCMA. These products have gathered 14 ...
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results